RXRX Recursion Pharmaceuticals, Inc.
$4.07
Recursion Pharmaceuticals, Inc. (RXRX) Earnings News
Earnings press releases, previews and reviews for Recursion Pharmaceuticals, Inc. (RXRX), newest first.
Wednesday
August 5, 2026
6:30 AM ET
Recursion Reports Second Quarter Financial Results; Genentech Options First Neuroscience Target into Early Discovery Program
Wednesday
July 29, 2026
8:30 AM ET
Recursion to Report Second Quarter 2026 Business Updates and Financial Results on August 5th
Wednesday
May 6, 2026
6:30 AM ET
Recursion Reports First Quarter Financial Results and Provides Business Update
Wednesday
April 29, 2026
7:59 AM ET
Recursion to Report First Quarter 2026 Business Updates and Financial Results on May 6